MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

Although specific microRNA (miRNA) signatures in classical Hodgkin lymphoma (cHL) have been proposed, their relationship with clinical outcome remains unclear. Despite treatment advances, a substantial subset of patients with advanced cHL are refractory to standard therapies based on adriamycin and...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Br J Haematol
Prif Awduron: Sánchez-Espiridión, Beatriz, Martín-Moreno, Ana M., Montalbán, Carlos, Figueroa, Vianihuini, Vega, Francisco, Younes, Anas, Medeiros, L. Jeffrey, Alvés, Francisco J., Canales, Miguel, Estévez, Mónica, Menarguez, Javier, Sabín, Pilar, Ruiz-Marcellán, María C., Lopez, Andrés, Sánchez-Godoy, Pedro, Burgos, Fernando, Santonja, Carlos, López, José L., Piris, Miguel A., Garcia, Juan F.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5291117/
https://ncbi.nlm.nih.gov/pubmed/23725219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12390
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg